Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Celastrol
Nanjing Legend Biotech Co.
Safety
1 trial -
Celastrol
Nanjing Legend Biotech Co.
Safety Issues
1 trial -
Celebrex
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Chinese herbal medicine
The First People's Hospital of Lianyungang
Acute on Chronic Liver Failure
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Vitamin D Deficiency
1 trial -
Chronotropic Incompetence Diagnostic Algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Cigarette
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
1 trial -
Ciprofloxacin
United Therapeutics Europe Ltd
Acute Lymphoblastic Leukaemia - Category
1 trial -
Citalopram
United Therapeutics Europe Ltd
Low Mood
1 trial -
Citrus Limonoid Beverage
United Therapeutics Europe Ltd
Hypercholesterolemia
1 trial -
ClearSight HPI Monitoring system
Grace Therapeutics
Anesthesia, Epidural
1 trial -
CocoaVia supplement
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
Coenzyme Q10
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Colchicine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transcatheter Aortic Valve Replacement
1 trial -
Colostrum supplementation for bone loss
Petros Pharmaceuticals
Osteopenia
1 trial -
Combination of targeted biopsy and systematic biopsy
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
Peking University Third Hospital
Prostate Cancer
1 trial -
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Computer Aided Diagnosis
Chinese University of Hong Kong
Upper Gastrointestinal Disorder
1 trial -
Cone Beam Computed Tomography scanning (CBCT)
United Therapeutics Europe Ltd
Endodontic Disease
1 trial -
Conservative treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Pancreatitis
1 trial -
Control
United Therapeutics Europe Ltd
Body Weight
1 trial -
Control (Standard treatment)
Grace Therapeutics
Moisture Associated Skin Damage
1 trial -
Controlled low central venous pressure (CLCVP) technology
The First People's Hospital of Lianyungang
Acute Kidney Injury
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources